These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15482960)

  • 41. Congenital myasthenic syndromes: clinical and genetic analysis of 18 patients.
    Abicht A; Müller-Felber W; Fischer P; Jakob I; Kürz L; Rudel R; Mortier W; Pongratz D; Lochmüller H
    Eur J Med Res; 1997 Dec; 2(12):515-22. PubMed ID: 9498929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. E-box mutations in the RAPSN promoter region in eight cases with congenital myasthenic syndrome.
    Ohno K; Sadeh M; Blatt I; Brengman JM; Engel AG
    Hum Mol Genet; 2003 Apr; 12(7):739-48. PubMed ID: 12651869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variable phenotypes associated with mutations in DOK7.
    Anderson JA; Ng JJ; Bowe C; McDonald C; Richman DP; Wollmann RL; Maselli RA
    Muscle Nerve; 2008 Apr; 37(4):448-56. PubMed ID: 18161030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A synonymous CHRNE mutation responsible for an aberrant splicing leading to congenital myasthenic syndrome.
    Richard P; Gaudon K; Fournier E; Jackson C; Bauché S; Haddad H; Koenig J; Echenne B; Hantaï D; Eymard B
    Neuromuscul Disord; 2007 May; 17(5):409-14. PubMed ID: 17363247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current understanding of congenital myasthenic syndromes.
    Engel AG; Sine SM
    Curr Opin Pharmacol; 2005 Jun; 5(3):308-21. PubMed ID: 15907919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutations.
    Schara U; Christen HJ; Durmus H; Hietala M; Krabetz K; Rodolico C; Schreiber G; Topaloglu H; Talim B; Voss W; Pihko H; Abicht A; Müller JS; Lochmüller H
    Eur J Paediatr Neurol; 2010 Jul; 14(4):326-33. PubMed ID: 19900826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Congenital endplate acetylcholinesterase deficiency responsive to ephedrine.
    Bestue-Cardiel M; Sáenz de Cabezón-Alvarez A; Capablo-Liesa JL; López-Pisón J; Peña-Segura JL; Martin-Martinez J; Engel AG
    Neurology; 2005 Jul; 65(1):144-6. PubMed ID: 16009904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Congenital myasthenic syndromes: A diverse array of molecular targets.
    Engel AG; Ohno K; Sine SM
    J Neurocytol; 2003; 32(5-8):1017-37. PubMed ID: 15034283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DOK7 congenital myasthenic syndrome.
    Palace J
    Ann N Y Acad Sci; 2012 Dec; 1275():49-53. PubMed ID: 23278577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical variability of CMS-EA (congenital myasthenic syndrome with episodic apnea) due to identical CHAT mutations in two infants.
    Barisic N; Müller JS; Paucic-Kirincic E; Gazdik M; Lah-Tomulic K; Pertl A; Sertic J; Zurak N; Lochmüller H; Abicht A
    Eur J Paediatr Neurol; 2005; 9(1):7-12. PubMed ID: 15701560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of previously unreported mutations in CHRNA1, CHRNE and RAPSN genes in three unrelated Italian patients with congenital myasthenic syndromes.
    Brugnoni R; Maggi L; Canioni E; Moroni I; Pantaleoni C; D'Arrigo S; Riva D; Cornelio F; Bernasconi P; Mantegazza R
    J Neurol; 2010 Jul; 257(7):1119-23. PubMed ID: 20157724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immature end-plates and utrophin deficiency in congenital myasthenic syndrome caused by epsilon-AChR subunit truncating mutations.
    Sieb JP; Kraner S; Rauch M; Steinlein OK
    Hum Genet; 2000 Aug; 107(2):160-4. PubMed ID: 11030414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term follow-up in patients with congenital myasthenic syndrome due to RAPSN mutations.
    Natera-de Benito D; Bestué M; Vilchez JJ; Evangelista T; Töpf A; García-Ribes A; Trujillo-Tiebas MJ; García-Hoyos M; Ortez C; Camacho A; Jiménez E; Dusl M; Abicht A; Lochmüller H; Colomer J; Nascimento A
    Neuromuscul Disord; 2016 Feb; 26(2):153-9. PubMed ID: 26782015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
    Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
    Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synaptic dysfunction in congenital myasthenic syndromes.
    Beeson D
    Ann N Y Acad Sci; 2012 Dec; 1275():63-9. PubMed ID: 23278579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Congenital myasthenic syndrome caused by two non-N88K rapsyn mutations.
    Maselli R; Dris H; Schnier J; Cockrell J; Wollmann R
    Clin Genet; 2007 Jul; 72(1):63-5. PubMed ID: 17594401
    [No Abstract]   [Full Text] [Related]  

  • 57. Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations.
    Wargon I; Richard P; Kuntzer T; Sternberg D; Nafissi S; Gaudon K; Lebail A; Bauche S; Hantaï D; Fournier E; Eymard B; Stojkovic T
    Neuromuscul Disord; 2012 Apr; 22(4):318-24. PubMed ID: 22088788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of Rapsyn in neuromuscular junction and congenital myasthenic syndrome.
    Liao X; Wang Y; Lai X; Wang S
    Biomol Biomed; 2023 Sep; 23(5):772-784. PubMed ID: 36815443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK.
    Gallenmüller C; Müller-Felber W; Dusl M; Stucka R; Guergueltcheva V; Blaschek A; von der Hagen M; Huebner A; Müller JS; Lochmüller H; Abicht A
    Neuromuscul Disord; 2014 Jan; 24(1):31-5. PubMed ID: 24183479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful treatment of congenital myasthenic syndrome caused by a novel compound heterozygous variant in RAPSN.
    Saito M; Ogasawara M; Inaba Y; Osawa Y; Nishioka M; Yamauchi S; Atsumi K; Takeuchi S; Imai K; Motobayashi M; Misawa Y; Iida A; Nishino I
    Brain Dev; 2022 Jan; 44(1):50-55. PubMed ID: 34565654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.